← Eichor
Study identifier: NCT07412925 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact Tourniquet Conservative Placenta Accreta Neonatal APGAR

Condition: Pregnancy · Placenta Accrete Spectrum · Tourniquets  ·  Sponsor: Kasr El Aini Hospital

PhaseNA
Planned participants100
Who can joinFemale, 20 Years to 40 Years
Healthy volunteersNo

About this study

Placenta accreta spectrum disorder (PAS) refers to a condition where the placenta fails to separate naturally after childbirth, which can cause significant maternal and neonatal complications, including severe bleeding, leading to increased morbidity and mortality. According to the pathological characteristics, PAS can be classified into three categories, including placenta accreta, placenta increta, and placenta percreta. Risk factors for PAS were identified as cesarean section (CS), hysteroscopy history, in vitro fertilization and embryo transfer and placenta previa, etc. It was reported that over 90% of the PAS cases were with prior cesarean delivery. In order to reduce the morbidity and mortality caused by PAS, guidelines were released from several international societies, including the Federation of Gynecology and Obstetrics (FIGO), Royal College of Obstetricians and Gynecologists (RCOG), the American College of Obstetricians and Gynecologists (ACOG) and Society of Obstetricians and Gynecologists of Canada (SOGC) recommending comprehensive multidisciplinary team (MDT) and expertise in pelvic and abdominal surgeries are essential for patients with PAS. Antenatal diagnosis of PAS is highly advisable, which is closely associated with surgery options, bleeding management and success of uterine preservation. Current diagnostic approaches include imaging examination, PAS prenatal grading system and MDT. Severe complications of PAS (particularly in the case of PP), such as subs…

This description comes directly from the study's public registry record.

Talk to the study team

Yassmine A Hamouda, MSC  ·  00201001680580  ·  yassmineamrabdelmegid@hotmail.com

Abdallah M Mousa, MD  ·  0020127664430  ·  Dr_abdallahmousa@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

kasr Al Aini Hospitals , Faculty of medicine , Cairo University , CairoCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07412925